Nuvasive reported $80.87M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US USD 4.59B 36M
Atricure ATRC:US USD 21.53M 523K
Baxter International BAX:US USD 2.63B 337M
Becton, Dickinson and BDX:US USD 2.68B 111M
Boston Scientific BSX:US USD 990M 32M
Cardiovascular Systems CSII:US USD 16.7M 429K
Cooper Companies COO:US USD 311.5M 20.2M
Dexcom DXCM:US USD 275.4M 28.7M
Edwards Lifesciences EW:US USD 252.2M 17.2M
Globus Medical GMED:US USD 65.5M 2.97M
Haemonetics HAE:US USD 139.61M 20.21M
Hologic HOLX:US USD 430.4M 13.3M
Inogen INGN:US USD 62.59M 5.47M
Insulet PODD:US USD 152.5M 43.4M
Integra Lifesciences IART:US USD 144.25M 973K
Intuitive Surgical ISRG:US USD 544.1M 38.8M
Johnson & Johnson JNJ:US USD 7.76B 29M
Medtronic MDT:US USD 2.48B 18M
Merit Medical Systems MMSI:US USD 158.6M 1.31M
Nuvasive NUVA:US USD 80.87M 4.89M
Orthofix International OFIX:US USD 30.57M 1.03M
Stryker SYK:US USD 1.68B 27M
Tandem Diabetes Care TNDM:US USD 100.12M 1.81M
Teleflex TFX:US USD 312.83M 2.88M
Zimmer Biomet Holdings Inc ZBH:US USD 488.2M 22.8M